Demo Sign up Log In

Myriad Genetics Inc (MYGN)

R&D Expenses

$105.80M

TTM · Period ending: Jun 30, 2026 · USD

MYGN R&D Expenses

Latest reported$105.80Mperiod endingJun 30, 2026

Latest reported$105.80Mperiod endingJun 30, 2026

MYGN TTM R&D Expenses ($17.00M → $105.80M)

TTM R&D Expenses

High-resolution chart · PNG

MYGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	33,818,143
Mar 31, 2001	34,344,004
Dec 31, 2000	34,248,602
Sep 30, 2000	31,097,566
Jun 30, 2000	28,106,769
Mar 31, 2000	26,233,000
Dec 31, 1999	24,000,000
Sep 30, 1999	23,500,000
Jun 30, 1999	23,500,000
Mar 31, 1999	23,900,000
Dec 31, 1998	23,300,000
Sep 30, 1998	22,600,000
Jun 30, 1998	23,000,000
Mar 31, 1998	21,900,000
Dec 31, 1997	20,600,000
Sep 30, 1997	20,600,000
Jun 30, 1997	18,500,000
Mar 31, 1997	17,500,000
Dec 31, 1996	17,000,000
Sep 30, 1996	14,800,000
Jun 30, 1996	10,700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.